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Abstract 
leukemia causes significant biochemical changes, serum biochemistry was studied to investigate the correlation 
of these fa5ctors to leukemia. Total 112 subjects were studied, 36 healthy individuals and 76 leukemia patients . 
Blood samples were collected in a gel and anticoagulant tubes from Tumors and blood diseases center in  
Kirkuk, Iraq. In this study Low level of acetylcholinesterase activity (P≤0.01) were observed in leukemia 
patients. And a number of biochemical parameters were measured, a Significantly increased at a level of 
probability (p≤ 0.01) in kidney function and liver functions the ,( Urea, Creatinine  ,Uric acid ) and (Glutamate  
oxaloacetate transaminase  GOT, Glutamate pyruvate  GPT, Alkaline phosphatase  (ALP) for patients with 
leukemia as compared with the control group. 
Keywords: leukemia ; acetylcholinesterase activity; Urea; Creatinine ; Uric acid;GOT ; GPT; ALP. 
1. Introduction  
Leukemia is some of non-integrative changes that characterize the accumulation of malignant white blood cells 
in the bone marrow and blood. These malignant cells accumulate as a result of either the proliferation and 
infiltration of malignant cells in the spleen, liver, lymph gland, brain, meninges, skin or bone marrow deficits 
that give signs of anemia Low thrombocytopenia and low immune cells [1]. Leukemia is classified as acute and 
chronic, depending on the origin of lymphocytes or septicemia into four types   : Acute Lymphocytic 
Leukemia(ALL) , Acute MyeIogenous Leukemia(AML), Chronic Lymphocytic Leukemia(CLL) and Chronic 
MyeIogenous Leukemia(CML)[2] . 
------------------------------------------------------------------------ 
* Corresponding author.  
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2018) Volume 42, No  1, pp 103-110 
 
104 
 
The general symptoms of leukemia include: general and stress, anemia and dizziness, recurrent fever and 
inflammation, loss of weight and loss of appetite, pain in the bones and joints, dyspnea, enlarged lymph nodes, 
liver and spleen, swelling of the feet and bruising small and small lesions that appear throughout the patient's 
body due to lack of blood vessels [3]. 
 The acetylcholinesterase enzyme is found in the confluence of neuromuscular, musculoskeletal and neural 
networks. It is produced in the endoplasmic network, which is released to the surface of the cell, called 
acetylcholine hydrolysis  (EC 3.1.1.7) [4] . Other cells (such as the cells that make up the fibers, the kidney cells 
,spleen,Luna and whiteblood cell [5]. It is also found in many tissues for example ( connective tissue, central 
nervous system, limbs, muscles, red blood cell walles, sensory nerves, motor nerves) and the efficacy of 
acetylcholinesters in sensory nerves less than motor nerves [6]. The function of the coenzyme acetylcholine 
enzyme is a neurotransmitter analysis and has a role in the regulation of cell death and the development and 
division of cells, which in turn indicates the role of enzymatic in the formation and development of cancer 
tumors [7].  
2. Materials and methods 
2.1 Selection of patients 
This study was conducted in the Department of Biochemistry lab in Kirkuk university, Iraq. It included 76 
patients diagnosed with Leukemia and 36 controls were also involved in the study. 
2.2 Serological Technique  
All were informed regarding the study and written consent was obtained. General information such as name, 
age, gender, acute illness, height, weight, and drugs usage etc was recorded in case of history performa. Blood 
samples were collected in a gel and anticoagulant tubes from normal and Leukemia  infected patients. The 
biochemical test included each of AChE activity was manually measured While  Creatinine  ,Uric acid , ALP 
were measured using the standard kits from Biolabo and GOT , GPT was performed by commercially available 
kit (RANDOX / UK). and Urea was performed by commercially available kit (Linear Chemicals / Spain).   
Table 1: Methods used to estimate the biochemical parameters 
Biochemical parameters The method 
AChE S-Acetylthiocholine Iodide method [8]. 
Creatinine Jaffe reaction [9]. 
Uric acid Fossati P, Prencipe L, Berti G [10]. 
ALP Belfield and Goldberg [11]. 
GOT and  GPT Ghosh [12]. 
Urea Enzymatic colorimetric method [13]. 
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2.3 Statistical analysis 
In this study the results include mean ±S.D and significant differences (P.Value) between groups that examined 
a available statical SPSS 17.0 significant differences was estimated as the p.value equal or less than 0.01 
3. Results and Discussion  
3.1 Acetylcholinesterase (AChE) 
The results shown in Table (2) show that the efficacy of acetylcholinesterase metabolism was significantly 
reduced at a probability level of (p ≤ 0.001 )for all age groups in the serum people with leukemia and both 
genders  compared to the healthy group. The highest rate of decline was in the fourth age group (60-64) years. 
This decrease in enzyme activity is due to its large use, especially with age. Enzyme has many important 
physiological functions and biochemical needed by the body, in addition to the primary role of the 
neurotransmitter analysis This enzyme is an important role in regulating cell proliferation and death and is an 
indicator of the diagnosis and exacerbation of cancer in patients. These results are consistent with previous 
research suggesting that serum vascular leukemia, liver cancer, and lung cancer [14][15] .Many patients with 
leukemia suffer from damage to liver tissue. It is therefore important to note that the cause of reduced efficacy 
of acetylcholinesterase is due to this damage, noting that the levels of AChE are correlated with the severity of 
the disease and the nutritional status of the patient [16] . 
Table 2: mean ± S.D of AChE activity for patients Leukemia  and control group 
Activity of ASChE (µmol/L/min) 
S.D ±  Mean)( 
Age  
(0.24± 8.97) Control (8)         
 >15 
(**0.62±5.311 ) Patients  (20)      
     (0.33±8.81) Control (10)       
16-30 
(**0.45±4.6) Patients (11)      
       (0.36±8.86) Control (7)        
31-45 
(**0.37±4.57) Patients (14)     
       (0.81±36.16) Control (11)      
46-60 
  (**9.2±28.05) Patients (31)     
 
3.2 The kidney function tests (Creatinin ,  Urea , Uric acid )    
The results in Table 3 showed a significant increase at ( p≤ 0.001) in serum creatinine ,Urea and uric acid in the 
serum group of patients compared to healthy patients. These results are consistent with previous research results, 
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indicating that levels of creatinine urea and uric acid in the serum were high in both leukemia and both genders  
And for all age groups. As noted, there is a rise in levels of creatinine urea and uric acid with age and that the 
reason for the rise in the level of creatinine is due to kidney function, which leads to high levels of creatinine 
because the creatinine is one of the most important indicators Which causes an idea of renal function and any 
abnormalities in renal function leads to elevated levels in the serum due to the lack of speed of glomerular 
filtration[17] . And the cause of urea increases and this rise in urea level occurs due to imbalance in the (brain  
blood) and its loss of function due to high oxidative stress, the urethra can cross the barrier to the serum, causing 
it to increase its concentration[18]. And the chemical treatment received by the leukemia patient contributes to 
an imbalance in the whole of the urethra, Kidney function associated with leukemia patients causes its 
accumulation in the body and therefore increases the levels of serum urea [19]. The reason for the rise of uric 
acid is due to the increased incidence of oxidative stress in the bodies of patients with leukemia, or due to the 
fact that it is an internal antioxidant that consists of oxidation of xanthine and hypoxanthine by the enzyme ( 
xanthine oxidase), which contributes to the removal of free radicals from the body and is very effective 
suppression Superoxide oxide, hydroxyl root, organic peroxylate and peroxy nitrite [20].It was also observed 
that there was an increase in the levels of uric acid with age and this is identical to previous research due to 
increasing the severity of the disease with age[21]. 
Table3: mean ± S.D of kidney function tests( Uric acid,  Urea, Creatinin)  activity for patients Leukemia  and 
control     group 
 
3.3 Liver function tests(AST, ALT, ALP)  
The results in Table 4 showed a significant increase at ( p ≤ 0.001 ) in the efficacy of enzymes (ALP, ALT, 
AST) in serum group of patients compared to healthy patients. These results were consistent with previous 
research results(AST, ALT, ALP) in the serum leukemia patients, both genders and for all age groups. It was 
also observed that there was an increase in the levels of the three enzymes with age. The reason for the increase 
in the effectiveness of the AST enzyme was due to the increased damage of liver, heart and kidney cells 
resulting from iron deposition. Red blood cell deficiency due to increased leukocytes at the expense of increased 
  Creatinin (mg/dl)                         Urea       (mg/dl)   Uric acid          (mg/dl) 
      
Age  
 
 
(S.D ±  Mean)  
(0.08±0.54) (1.4±18.4 )  (0.12 ±3.94 ) Control (8)   
 >15 (**0.06±1.19)  (**2.2±49.2) (**0.45 ±7.1 ) Patients  (20)      
(0.15±0.61) (2.5±26.1) (0.16±3.91) Control (10 ) 
16-30 (**0.08±1.38) (**2.4±56.3)   (**0.34±8.23)  Patients  (11)      
(0.18±0.76) (6.02±33.94)  (0.53±4.5)  Control(7)    
31-45 (**0.16±1.53) (**2.15±59.09) (** 0.40±9.1) Patients  (14)      
(0.08 ±1.04) 6.75 ±37.72) ( 0.50±5.47) Control(11) 
46-60 (**0.15±1.63 )  (** 1.60±60.3) (**0.53 ±9.69) Patients  (31)      
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N To Recurrent blood or obstruction of hepatic channels [22,23] .It is also indicated that the increase in the 
efficacy of this AST enzyme may result in an increase in the number of cancer cells[24]. The cause of ALT 
elevation is due to hepatic infiltration, because leachate disorders cause an imbalance in the mitochondrial walls 
of the cell or increase the enzyme's effectiveness to liver damage due to chemotherapy [23]. It may also be due 
to an increase in the number of cancer cells [25]. The reason for the rise in the level of ALP, especially among 
children, is the growth of children during this age period before reaching puberty [26]. These results are 
consistent with earlier research suggesting that ovarian cancer, prostate, lung, breast and pharynx [27] . And 
acute lymphocytic cancer [28] . And colon cancer  [29]. are more effective Hepatitis and liver cirrhosis [30]. 
The increase in the efficacy of ALP may be due to increased effectiveness of the real pathogenesis pathway 
[31]. 
Table 4: mean ± S.D of Liver function tests( GOT, GPT ,ALP) activity for patients Leukemia  and control     
group 
    (U/L)   ALP GPT(U/L)      GOT(U/L) Age  
                                     (S.D ±  Mean)     
(0.481±39.9) (2.02±15.4 ) (1.48 ± 13.5) Control (8)   
 >15 (**33.2±220.2) (**2.2±47.4) (**2.1 ±48.05 ) Patients  (20)      
(0.35±40.53) (1.12±17.21) (0.62±15.7) Control (10 ) 
16-30 (**33.5±164.9) (**1.1±69.4) (**10.5±68.3)  Patients  (11)      
(0.28±41.3)  (1.51±18.7) (**0.70±15.5) Control(7)    
31-45 (**35.6±169.3)  (** 11.3±68.4) (**8.9±  69.8) Patients  (14)      
(0.46 ±41.2) (3.11±20.3) (0.39 ±15.9) Control(11) 46-60 
(**41.5±183.5 ) (**11 ±63) (**7.6 ±67.1) Patients  (31) 
 
4. Concleusion 
An investigated of Leukemia case was successfully performed, studying it's effect  on the acetylcholinesterase  
activity. The main concluded points from this research were summarized as follow : the decrease of 
acetylcholinesterase enzyme activity level ; increasing the level of ALT ,AST,ALP ,Urea, Uric acide and 
Creatinin . 
5. Recommendations  
The present study recommends the following                                                              
1. Isolation of other enzymes related to Leukemia . 
2. The possibility of using the enzymes AChE as biochemical parameters 
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to follow the severity of the disease.                                                                     
3.Study the effect of drugs on the biochemical variables in people with Leukemia .        
References                                                                                                                                                   
[1] Dohner ,H., Weisdrof ,D. J., Bloomfield ,C.D. (2015). Acute myeloid leukemia. N E J Med., 
373(12):1136-52.                                                                                           
[2]  Manisha Pokhare, B.C., 2012. Leukemia : A Review Article. , 2(3), pp.397–407. 
[3] Davis, A.S., Viera ,A.J., Mead, M.D. (2014). Leukemia: An overview for primary care. American 
Family Physicion ,89(9):731-738                                                          
 [4] Gupta ,A., Mittal ,A., Jha ,K., Kummar ,A.(2011) . Natures treasures :Plants acting on colon cancer. J. 
of Stress Phys. Bioch. 7(4): 217-231                                                
 [5] Xi ,H. J., Wu, R. P., Liu, J. J. , Zhang, L. J.,Li ,Z. S.(2015).Role of acetyl         cholinesterase in lung 
cancer. Thorac Cancer 6(4):390-398.                                                          
[6] Čolović, M. B., Krstić, D.Z. , Lazarević-Pašti, T. D., Bondžić, A. M, and Vasić,V. M.(2013). 
Acetylcholinesterase inhibitors: Pharmacology and Toxicology. Curr Neuropharmacol.; 11(3): 315–
335 
[7] Zhang ,X.J., Greenbreg,D  S.(2012). Acetyl cholinesterase involvement in apoptosis. Front  Mol Neuro 
Sci.,5:40    
[8] Ellman G.L., Courtney, K.D., Andrews, Vjr, Featherstone R.M. A new and rapid colorimetric 
determination of acetylcholinesterase activity. Biochem Pharmacol, 1961; 7: 88-95.                                                                                                                
[9]Aleibaji , Saba Zaki , Omar , Doaa Hussein "Abiochemical Study Of ribonioklease enzyme in serum and 
tissue of uterine tumors , Journal of Al-Rafidain Science,2013.24(5) RNase (64-80)   
[10] Fossati P, Prencipe L, Berti G. Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone 
chromogenic system in direct enzymic assay of uric acid in serum and urine. Clinical chemistry. 1980 
Feb 1;26(2):227-31 
[11] Belfield, A.; and Goldberg, D.M. (1971). "Alkaline phosphatase determination in enzymes". 12.p: 561-
573.                                                                                                
[12] Ghosh J. Role of Nitric Oxide in Salmonella Infection. Indian Journal of Clinical Biochemistry. 2012 
Jul 1;27(3):306- 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2018) Volume 42, No  1, pp 103-110 
 
109 
 
[13] Wu A, Tymoszuk P, Haschka D, Heeke S, Dichtl S, Petzer V, Seifert M, Hilbe R, Sopper S, Talasz H, 
Bumann D. Salmonella utilizes zinc to subvert anti-microbial host defense of macrophages via 
modulation of NF-κB signaling. Infection and immunity. 2017 Sep 5:IAI-00418                                                                                   
[14] Betty Ciesla, 2012. Hematology in practice 2. ed., Philadelphia : F.A. Davis, cop, 11, pp.159-188                                                                                                           
[15] Manisha Pokhare, B.C., 2012. Leukemia : A Review Article. , 2(3), pp.397–407. 
[16] Hoffman,Roma . Hematology: Basic Principles and Practice (4th.Ed )2005 
[17] Radivoyevitch T., Sachs, R.K., Gale, R.P., Molenaar, R.J., Brenner, D.J., Hill,B.T., Kalaycio, 
M.E.(2015).Defining AML and MDS second cancer riskdynamics after diagnoses of first cancers 
treated or not with radiation",Leukemia, 2015: 258                                                                                                                          
[18] Vardiman, J.W. " Chronic myelogenous leukemia , BCR-ABL 1"Am.J.clin. pathol 2009;. 132:250-226 
[19] Davis, A.S., Viera ,A.J., Mead, M.D. (2014). Leukemia: An overview for primary care. American 
Family Physicion ,89(9):731-738. 
[20] Cashen AF, Schiller GJ, O'Donnell MR, DiPersio JF. Multicenter,phase II study of decitabine for the 
first-line treatment of older patients with acute myeloid leukemia. J Clin Oncol. Feb 1 2010;28(4):556-
61. 
[21] Guide book on chronic Lymphocytic Leukemia;August 24,2010                              
[22] Radivoyevitch T., Sachs, R.K., Gale, R.P., Molenaar, R.J., Brenner, D.J., Hill,B.T., Kalaycio, 
M.E.(2015).Defining AML and MDS second cancer riskdynamics after diagnoses of first cancers 
treated or not with radiation",Leukemia, 2015: 258 
[23] Davis, A.S., Viera ,A.J., Mead, M.D. (2014). Leukemia: An overview for primary care. American 
Family Physicion ,89(9):731-738.    
[24] Inaba, H., Greaves, M., Mullighan, C.G. (2013). Acute lymphoblastic leukaemia.Lancet. 
381(9881):1943-1955 
[25] Gupta ,A., Mittal ,A., Jha ,K., Kummar ,A.(2011) . Natures treasures :Plants acting on colon cancer. J. 
of Stress Phys. Bioch. 7(4): 217-231. 
[26] i ,H. J., Wu, R. P., Liu, J. J. , Zhang, L. J.,Li ,Z. S.(2015).Role of acetyl cholinesterase in lung cancer. 
Thorac Cancer 6(4):390-398. 
[27] Čolović, M. B., Krstić, D.Z. , Lazarević-Pašti, T. D., Bondžić, A. M, and Vasić,V. M.(2013). 
Acetylcholinesterase inhibitors: Pharmacology and Toxicology. Curr Neuropharmacol.; 11(3): 315–
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2018) Volume 42, No  1, pp 103-110 
 
110 
 
335. 
[28] Zhang ,X.J., Greenbreg,D. S.(2012). Acetyl cholinesterase involvement in apoptosis. Front Mol Neuro 
Sci.,5:40. 
[29] Miswon, N.H. , Hashim,Z. , How, V., Chokeli, R. (2015).Blood Cholinesterase Level and Learning 
Ability of Primary School Children in an Agricultural Village, Tanjung Karang, Malaysia. British 
Journal of Medicine & Medical Research.8(1): 52-60. 
[30] Pohanka, M. (2012). Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and 
toxicology. Internat.J.Molecular.Scie. 13 (12):2219–2238. 
[31] Katzung ,B.G. (2001).Basic and clinical pharmocology introduction toautonomic pharmacology (8ed) 
.The McGraw Companies. pp.75-91. 
 
 
 
